Everyone is the customer
A product pitched to hospitals, group practices and payers in the same words reaches none of them. The ideal customer profile is too broad and the message too vague to test.
GTM Strategy
A go-to-market plan built for healthcare buyers and long sales cycles
We define who you sell to, what each person on the buying committee needs to hear, and which channels and referral partners produce qualified pipeline.
Short answer
What is a GTM strategy for a healthcare business?
A go-to-market strategy defines who you sell to, what you promise, how you price and package it, which channels reach buyers and how you measure pipeline. In healthcare it also accounts for buying committees, security reviews and regulated claims, so the plan speaks to each stakeholder rather than to one imagined decision maker.
The problem
Problems this service solves
One message for a whole committee
The clinical champion cares about workflow, finance about payback, IT security about data handling and compliance about claims. A deck written for one of them stalls with the other three.
Deals that stall in review
Opportunities stop in security questionnaires, legal review or a value analysis committee because the proof was never prepared. Sales hears nothing back for weeks.
Referrals with no structure
Provider groups depend on physician offices, employers or discharge planners, yet nobody tracks which sources convert. Some referral arrangements also carry legal risk.
Context
Why this is harder in healthcare, and where it opens up
What makes it hard
- Procurement is layered. A buyer may need clinical, operational, finance, IT security and compliance sign-off before a pilot can start.
- Adoption differs by segment. Menlo Ventures measured 27% of surveyed health systems, 18% of outpatient providers and 14% of payers as having implemented domain-specific AI tools in 2025, so one pitch lands differently in each.
- Access is not deployment. NHS England announced a Midlands procurement route covering 1,239 GP practices and 70,000+ clinicians across 15 trusts, which is access to procurement, not completed rollout.
- Claims are regulated. HIPAA generally requires valid authorization to use or disclose protected health information for marketing, and every performance claim to a buyer needs substantiation.
Where the opportunity is
- Choose one segment and one buyer problem first. A narrow profile speeds message testing and gives sales a list it can actually work.
- Prepare the proof pack before the first meeting: security summary, data flow diagram, implementation plan and pricing logic.
- Use partners and referrers deliberately, with a defined role for each: implementation partners, marketplaces, associations and physician offices.
- Give sales and customer success one story, so what is promised matches what gets implemented.
How it works
The mechanics, in order
- 01
Define the ICP from evidence
We review your best and worst customers or referral sources, then describe the segment in operational terms: specialty, site count, payer mix, systems in use and contract cycle.
- 02
Map the buying committee
For each account type we list the roles involved, such as clinical champion, practice manager, finance, IT security and compliance, and what each needs to see to say yes.
- 03
Write positioning and stakeholder messages
One positioning statement, then a version of the proof for each role. We test them in real conversations before they become pages and decks.
- 04
Choose the offer, channels and partners
Pricing and packaging logic, outbound, events, content, partners and referrals, each with an owner and a pipeline measure.
- 05
Set stages and a review rhythm
Stage definitions, conversion targets taken from your own baseline and a monthly review of what is moving and what is stuck.
Human + AI
What AI does, and what people own
AI makes research, drafting and analysis faster. Positioning, pricing and every claim made to a buyer stay with your leaders.
AI handles
- Researches target accounts and summarizes public information on strategy, systems and leadership.
- Drafts message variants and outbound sequences for each stakeholder role.
- Clusters call recordings and win-loss notes to surface recurring objections.
- Scores inbound leads against the ICP and flags those needing a person quickly.
People decide and review
- The founder or commercial lead owns positioning and decides which segment to win first.
- A clinical or subject-matter reviewer checks every claim about performance, safety or outcomes.
- Sales leaders decide how deals are qualified, discounted and handed to customer success.
- The compliance officer approves referral arrangements, outbound rules and any use of protected health information.
What we build
What is included
01
ICP and segmentation
Target segments, trigger events and account lists defined from your own customer data rather than assumption.
02
Positioning and messaging
A positioning statement plus proof points for the clinical champion, operations lead, finance, IT security and compliance.
03
Pricing and packaging logic
What a pilot includes, how tiers and scope are drawn and how procurement can compare you with alternatives. We work on the logic, not invented price points.
04
Sales enablement
Battlecards, a security and compliance answer library, demo scripts and a reference process, so reps stop improvising on questionnaires.
05
Channels, partnerships and referrals
Plans for outbound, events, content, partner and referral programs, with the follow-up and reporting handled through revenue operations.
06
Demand generation plan
Stage definitions and a reporting view linking activity to meetings and opportunities, with campaigns built through digital marketing.
Use cases
Examples from healthcare operations
Illustrations of how this work looks in practice. They describe workflows, not client results.
A health-tech founder choosing a first market
A founder with early customers on both sides of the Atlantic decides which market to pursue first, builds the security evidence pack and writes separate messages for the clinical lead and the information governance team.
Digital HealthA billing company winning practice clients
The company positions on client reporting and onboarding, targets specialties with heavy denial work and equips sales with a sample monthly report.
Medical Billing & RCMA device maker preparing for value analysis
The MedTech team builds a hospital value analysis packet with evidence tied to intended use and trains reps on what they may and may not claim.
MedTech & DevicesA provider group growing referrals
A specialist group maps its referral sources, sees which physician offices send the most referrals and sets a follow-up cadence and liaison program.
Medical ClinicsGrowth link
From positioning to pipeline you can inspect
A GTM plan is only useful if you can see it working. We define stages from first touch to signed contract, give each stage an owner and a measure, and align the plan with your AI strategy so investment follows the segments you are trying to win.
- Attract: a defined ICP and content that answers the questions each committee member asks.
- Convert: stage definitions, a proof pack and clear next steps that keep deals moving through security and legal review.
- Retain: onboarding and customer success plans that match what sales promised, which protects renewals and references.
- Grow: expansion paths inside accounts and referral loops from satisfied customers and partners.
Our approach
How an engagement runs
Phase 1
Diagnose
Review customers, lost deals, referral sources and current messaging, then interview sales, customer success and a few buyers.
Phase 2
Position
Agree the ICP, positioning and stakeholder messages, tested in live conversations.
Phase 3
Equip
Build the proof pack, answer library, battlecards, partner and referral rules and pipeline definitions.
Phase 4
Launch and tune
Run the first channels, review pipeline measures monthly and adjust from what the data shows.
Outcomes
What usually improves
A narrower, workable target list
Sales works named segments and accounts instead of the whole market.
Fewer stalled deals
Proof is ready before security and legal review, so those reviews raise fewer surprises.
Messages that fit each role
Clinicians, finance and IT each see the evidence they need, in their own terms.
Pipeline reporting people trust
Everyone uses the same stage definitions, so forecasts and reviews are comparable month to month.
What this depends on
Healthcare sales cycles are long and depend on the product, the buyer and the budget calendar. A plan can improve targeting, message fit and follow-through, but it cannot shorten a procurement process the buyer controls. We do not promise pipeline, win rates or revenue; we set measures from your baseline and review them honestly.
Industries
Where it fits best
01Digital HealthDigital health companies face long cycles, security questionnaires and, in the NHS market, a DTAC assessment, so the proof pack matters as much as the pitch.02MedTech & DevicesMedTech sellers need positioning that matches authorized intended use and evidence a hospital value analysis committee can compare.03Medical Billing & RCMBilling and RCM firms are B2B businesses too: they win practices on reporting clarity, onboarding and a specific specialty focus.04Healthcare ConsultingConsultancies sell expertise, so GTM work turns it into a narrow point of view, a defined buyer and a repeatable first engagement.05Labs & DiagnosticsLabs and imaging providers sell to referrers and health systems, where referral source tracking and client portal inquiries drive the plan.06MSOs & GroupsMulti-site groups grow same-site volume through referral capture, and need a plan that every location can run in the same way.
Limits
What to watch out for
- Paying for referrals is risky. In a June 2026 advisory opinion (26-15), HHS-OIG found one online referral-software payment arrangement unfavorable under the federal Anti-Kickback Statute. That opinion turns on its own facts, but any program that rewards referrals needs legal review before launch. Check with qualified counsel.
- Using protected health information in outreach needs the right permission. HHS guidance says HIPAA generally requires a valid authorization for use or disclosure of PHI for marketing.
- NHS-market products need a DTAC assessment covering clinical safety, data protection, technical security, interoperability, usability and accessibility. DTAC is not MHRA device approval, and organizations accessing NHS patient data or systems also complete the Data Security and Protection Toolkit, whose 2025-26 submission deadline was 30 June 2026.
- Procurement access is not a sale. A framework, marketplace listing or supplier registry puts you on a list; it is neither an endorsement nor a purchase decision.
Questions
Frequently asked questions
How is a healthcare GTM strategy different from a general B2B one?
Healthcare buyers decide in committees and ask for security, privacy and clinical safety evidence. Claims are regulated, and cycles run through budgets and review boards. The plan has to speak to each stakeholder and prepare proof early.
Do you set our prices?
We work on pricing and packaging logic: what a pilot includes, how scope and tiers are drawn and how a buyer can compare you with alternatives. Final price points depend on your costs and market, which only you hold.
Can AI write our outbound messages?
AI can research accounts and draft variants, but a person reviews every message and every claim. Rules differ by channel and country, so outbound design sits alongside AI governance and your compliance owner.
We sell in the US and the UK. Do we need two plans?
Usually one positioning and two proof packs. US buyers tend to ask about HIPAA, business associate agreements and interoperability. NHS buyers ask for DTAC evidence and data security assurance.
How do referral programs work for a provider group?
We map your referral sources, track which convert and set a follow-up cadence for the offices that matter most. Programs that pay or reward referrals get legal review first. Tracking comes before anything else, because a clinic cannot prioritize sources it has not measured.
How do we know the GTM plan is working?
We agree measures before launch: qualified meetings, stage-to-stage conversion, referral conversion, lead response time and sales cycle length against your own baseline. Early signals come from message response, and revenue results follow later.
Know who you sell to and what each person needs to hear
Book a discovery call to review your segments, your last few lost deals and your referral sources. You will leave knowing where positioning is weakest and what to fix first.